Saccharomyces boulardii

Saccharomyces cerevisiae var. boulardii also Saccharomyces boulardii

Family
The yeast family · Saccharomycetaceae
  • en S. boulardii
  • en Saccharomyces boulardii CNCM I-745

Watch out

At home

Not a home remedy. It's a freeze-dried medicine-grade yeast sold in capsules and sachets, with no home version. Don't open capsules near anyone who is very ill or has a central line.

My tummy is… the evidence in full

LooseStudied & supportedmoderate certainty · children taking antibiotics

S. boulardii (mostly CNCM I-745) capsules or sachets taken with antibiotics, to prevent diarrhoea

Paediatric gastroenterologists in Europe (ESPGHAN), reviewing strain-specified trials with GRADE, rated the evidence that S. boulardii prevents antibiotic-associated diarrhoea in children as moderate quality and recommended it. A 2015 meta-analysis found it cut the risk in children from about 21% to 9%. For C. difficile diarrhoea specifically, the evidence in children is low quality.

Sources: Journal of Pediatric Gastroenterology and… 2016clinical guidelineAlimentary Pharmacology & Therapeutics 2015systematic reviewCochrane Database of Systematic Reviews 2019Cochrane review

LooseSome evidenceadults taking antibiotics

S. boulardii capsules or sachets taken with antibiotics, to prevent diarrhoea

A 2015 meta-analysis of 15 trials in 3114 adults found S. boulardii cut antibiotic-associated diarrhoea from about 17% to 8%, though not C. difficile diarrhoea. The review used GRADE, but its abstract doesn't give the certainty for adults, and a 2025 Cochrane review rated the evidence for probiotics as a group, in adults and children, as low certainty for this outcome.

Sources: Alimentary Pharmacology & Therapeutics 2015systematic reviewCochrane Database of Systematic Reviews 2025Cochrane review

LooseSome evidencevery low certainty · children with acute gastroenteritis

S. boulardii given during acute gastroenteritis, alongside rehydration

A 2020 meta-analysis of 29 trials found children given S. boulardii had diarrhoea for about a day less and left hospital a little sooner, but most trials were poorly concealed and unblinded, and the reviewers rated the evidence low to very low quality.

Sources: Alimentary Pharmacology & Therapeutics 2020systematic review

Irritable (IBS)Not enough evidenceadults with irritable bowel syndrome

S. boulardii CNCM I-745 alone

A 2026 strain-by-strain meta-analysis of probiotics for IBS found conflicting results for this strain.

Sources: Journal of Clinical Medicine 2026systematic review

How we grade the evidence